With drug importation champion Senator Byron Dorgan’s departure from the Senate, advocates for lower drug prices were concerned that no one would step up to the plate. Raising the issue from the dead, in an interview yesterday with IowaPolitics.com, Senator Chuck Grassley (R-IA), who supported the Dorgan bill, has boldly picked up the torch unambiguously voicing his continuing support of the legislation to allow lower priced drug imports.
Senator Grassley’s frames the issue as follows:
“Giving American consumers access to imported prescription drugs would force pharmaceutical companies to re-evaluate this unfair pricing strategy and drive U.S. prices down. It’s a free-trade issue. American consumers are able to buy almost every other product available from other countries. The same should be true for prescription drugs.” (more…)
Tagged with: Dorgan, Drug Importation, generic drugs, Heath Care Act, IowaPolitics.com, lower prices, Patient Protection and Affordable Health Care Act of 2009, personal drug importation, pharmaceutical companies, Pharmaceutical Market Access and Drug Safety Act, prescriptions, Senator Chuck Grassley, Senator Herb Kohl, United States
At the beginning of the 21st century, what started out as a trickle of American seniors buying drugs in Canada in order to save money, turned into millions of Americans over the past decade buying their drugs from Canadian and other international pharmacies. At that time, the demand was largely due to the fact that Medicare did not include a drug benefit, and tens of millions of seniors had to pay entirely out-of-pocket for their prescriptions drugs. Not only has this industry helped millions of Americans afford prescription drugs and created public awareness about international drug price disparities, but it has affected U.S. healthcare policy, leading to greater health coverage. (more…)
Tagged with: Canadian pharmacies, Dorgan, Drug Prices, Healthcare Reform, international pharmacies, Medicare, Medicare Drug Plans, Online Pharmacies, policy, seniors, Snowe
Senator Byron Dorgan (D-SD), who is leaving congress at the end of this term, continues to stand up to the pharmaceutical industry and on behalf of American consumers, as he is once again trying to push forward legislation that legalizes drug importation in a manner that could make prescription medication more affordable. In December of 2009, Dorgan introduced an amendment to H.R. 3590: Patient Protection and Affordable Care Act to legalize drug importation, which received 51 yeas and 48 nays, falling short of the 60 votes needed for passage. Now Dorgan plans to introduce his legislation as an amendment to the food safety bill, which is sponsored by John Dingell (D-Mich). Dingell, however, is an adamant opponent to drug importation and is against attaching the amendment to his bill. Read the details in The Hill.
Tagged with: Dorgan, Drug Prices, Healthcare Reform, Online Pharmacies, personal drug importation, pharmaceutical companies, phrma, policy